An AML Targeted Duplex Sequencing Assay That Can Detect Measurable Residual Disease (MRD) at a Sensitivity Better Than 0.01% Variant Allele Frequency
Autor: | McElwain, Mark, Olson, Janice M, Zannette, Camila, Nguyen, Karen, Fitzgerald, Devon M, Lee, Isabel Y, Schmidt, Elizabeth, Vavra, Kevin C, Gillis, Laura B, Gordon, Kelly J, Wakeman, Wayne B, Smith, Thomas H, Salk, Jesse J, Higgins, Jake, Harrell, Jill C, Chu, Frances, Meredith, Gavin D |
---|---|
Zdroj: | In Transplantation and Cellular Therapy February 2024 30(2) Supplement:S101-S102 |
Databáze: | ScienceDirect |
Externí odkaz: |